https://marketrealist.com/2018/02/behind-performance-astrazenecas-daliresp-tudorza-duaklir/2018-03-06T12:30:32.000Zdaily0.8https://media.marketrealist.com/brand-img/GnKWqo05H/0x0/uploads/2018/02/Daliresp.pngdaliresphttps://marketrealist.com/2018/02/look-performance-astrazenecas-symbicort-pulmicort-2017/2018-03-05T15:30:42.000Zdaily0.8https://media.marketrealist.com/brand-img/PQ5I9MBRr/0x0/uploads/2018/02/Symbicort.pngsymbicorthttps://marketrealist.com/2018/02/look-performance-astrazenecas-tagrisso-2017/2018-03-01T12:33:36.000Zdaily0.8https://media.marketrealist.com/brand-img/hVHCCVeQs/0x0/uploads/2018/02/Tagrisso.pngtagrissohttps://marketrealist.com/2018/02/will-energy-continue-wild-ride-2018/2018-02-28T21:16:44.000Zdaily0.8https://media.marketrealist.com/brand-img/JIJ_T5Ap2/0x0/uploads/2018/02/Part-5-Direxion-1.jpgpartdirexionhttps://marketrealist.com/2018/02/will-technology-sector-keep-blaze/2020-11-20T19:47:02.643Zdaily0.8https://media.marketrealist.com/brand-img/rgEzxmPRn/0x0/uploads/2018/02/Part-3-DIREXION-1-1.jpgpartdirexionhttps://marketrealist.com/2018/02/the-geographic-segments-of-integer-holdings-corporation/2018-03-01T02:19:45.000Zdaily0.8https://media.marketrealist.com/brand-img/NTHWfIQ7J/0x0/uploads/2018/02/ITGR-geographic-segments-1.pngitgrgeographicsegmentshttps://marketrealist.com/2018/02/heres-how-comcasts-theme-park-business-performed-in-4q17/2020-11-20T20:24:51.511Zdaily0.8https://media.marketrealist.com/brand-img/U6pFIf4Gr/0x0/uploads/2018/02/10-2.jpgmtatmghttps://marketrealist.com/2018/02/align-technology-to-execute-on-key-strategic-priorities-in-2018/2018-03-02T15:30:34.000Zdaily0.8https://media.marketrealist.com/brand-img/gdIF99oaQ/0x0/uploads/2018/02/strategic-priorities-1.pngstrategicprioritieshttps://marketrealist.com/2018/02/align-technologys-invisalign-average-selling-price-and-volumes/2018-03-01T12:32:01.000Zdaily0.8https://media.marketrealist.com/brand-img/7EdHjgZee/0x0/uploads/2018/02/Invisalign-shipment-trend-1.pnginvisalignshipmenttrendhttps://marketrealist.com/2018/02/warren-buffett-to-investors-never-buy-a-stock-using-leverage/2018-02-28T16:55:08.000Zdaily0.8https://media.marketrealist.com/brand-img/ccHLamGPF/0x0/uploads/2018/02/Higher-Leverages-Caused-Market-Disturbances-2018-02-28-1.jpghigherleveragescausedmarketdisturbanceshttps://marketrealist.com/2018/02/fiat-chryslers-european-sales-rose-in-january-2018/2018-03-02T14:00:11.000Zdaily0.8https://media.marketrealist.com/brand-img/YxfFh0Xzz/0x0/uploads/2018/02/8-23.pngocymwhttps://marketrealist.com/2018/02/comparing-china-and-us-vehicle-sales-in-january-2018/2018-02-28T14:50:10.000Zdaily0.8https://media.marketrealist.com/brand-img/K_WoY5Mw3/0x0/uploads/2018/02/2_corrected.pngcorrectedhttps://marketrealist.com/2018/02/how-is-the-volatility-index-impacting-gold/2018-02-28T16:10:10.000Zdaily0.8https://media.marketrealist.com/brand-img/rNxDUJV6g/0x0/uploads/2018/02/gold-versus-VIX-1.pnggoldversusvixhttps://marketrealist.com/2018/02/edwards-lifesciences-strong-product-portfolio-bodes-well/2018-02-28T19:58:40.000Zdaily0.8https://media.marketrealist.com/brand-img/IFJ6OaghP/0x0/uploads/2018/02/EW-product-areas-1.pngewproductareashttps://marketrealist.com/2018/02/jefferies-revises-target-prices-for-diamond-offshore-noble/2020-11-20T18:32:20.982Zdaily0.8https://media.marketrealist.com/brand-img/M3SVLFT35/0x0/uploads/2018/02/DO-Analyst-Rating-2-1.jpgdoanalystratinghttps://marketrealist.com/2018/02/urea-prices-rose-last-week/2018-02-27T16:05:02.000Zdaily0.8https://media.marketrealist.com/brand-img/jvmwRnMmB/0x0/uploads/2018/02/Urea-Prices-2018-02-26-1.jpgureapriceshttps://marketrealist.com/2018/02/analyzing-boston-scientifics-business-segments/2018-03-02T18:18:44.000Zdaily0.8https://media.marketrealist.com/brand-img/wOWCoJJcW/0x0/uploads/2018/02/BSX2.pngbsxhttps://marketrealist.com/2018/02/how-has-universal-health-services-fared-compared-to-peers/2018-02-27T20:45:42.000Zdaily0.8https://media.marketrealist.com/brand-img/f2hWTNaFd/0x0/uploads/2018/02/UHS-revenue-sources-1.pnguhsrevenuesourceshttps://marketrealist.com/2018/02/why-user-revolt-over-snapchats-redesign-may-not-be-a-negative/2020-12-04T15:53:08.746Zdaily0.8https://media.marketrealist.com/brand-img/a4bav7I97/0x0/uploads/2018/02/Snap-Inc.-revenue-4-1.pngsnapinchttps://marketrealist.com/2018/02/what-helped-microsoft-capture-the-largest-market-share/2021-05-04T14:32:46.672Zdaily0.8https://media.marketrealist.com/brand-img/poFFSd8fq/0x0/uploads/2018/02/cloud-leader-1.pngcloudleaderhttps://marketrealist.com/2018/02/understanding-freeports-capital-allocation-strategy/2018-02-28T12:31:42.000Zdaily0.8https://media.marketrealist.com/brand-img/aowgEXxPb/0x0/uploads/2018/02/part-6-freeport-capital-allocation-1.pngpartfreeportcapitalallocationhttps://marketrealist.com/2018/02/an-insight-into-alkermes-rd-pipeline/2018-02-27T12:33:47.000Zdaily0.8https://media.marketrealist.com/brand-img/mhmrL2gSG/0x0/uploads/2018/02/ALKS-RD-pipeline-1.pngalksrdpipelinehttps://marketrealist.com/2018/02/newmont-minings-project-pipeline-strong-gets/2018-02-27T12:33:14.000Zdaily0.8https://media.marketrealist.com/brand-img/nJLKiRM-m/0x0/uploads/2018/02/Project-pipeline-3-1.pngprojectpipelinehttps://marketrealist.com/2018/02/what-drove-medtronics-cardiac-and-vascular-group-in-3q18/2018-02-27T12:32:48.000Zdaily0.8https://media.marketrealist.com/brand-img/H3eGARU3p/0x0/uploads/2018/02/CVG.pngcvghttps://marketrealist.com/2018/02/how-wendys-valuation-multiple-compares-to-its-peers/2018-02-28T12:31:12.000Zdaily0.8https://media.marketrealist.com/brand-img/L5DNTYXaW/0x0/uploads/2018/02/7-11.jpgnyxmqhttps://marketrealist.com/2018/02/what-analysts-expect-for-wendys-revenue-in-2018/2018-02-27T12:32:35.000Zdaily0.8https://media.marketrealist.com/brand-img/BF6N6Y39j/0x0/uploads/2018/02/4-27.jpgncynwhttps://marketrealist.com/2018/02/what-drove-wendys-same-store-sales-growth-in-4q17/2018-02-26T19:40:03.000Zdaily0.8https://media.marketrealist.com/brand-img/DAoGcXNpk/0x0/uploads/2018/02/3-30.jpgmyzmahttps://marketrealist.com/2018/02/how-the-drug-store-industry-is-changing/2018-02-26T13:10:58.000Zdaily0.8https://media.marketrealist.com/brand-img/DPN6PhPNa/0x0/uploads/2018/02/5-16.jpgnsxnghttps://marketrealist.com/2018/02/reviewing-albemarles-stock-performance-since-3q17/2018-02-23T20:08:58.000Zdaily0.8https://media.marketrealist.com/brand-img/xNTLkX6xq/0x0/uploads/2018/02/Title-3-1.pngtitlehttps://marketrealist.com/2018/02/fomcs-review-of-economic-situation-signals-strong-us-economy/2018-02-23T21:10:02.000Zdaily0.8https://media.marketrealist.com/brand-img/Y1KT68UBA/0x0/uploads/2018/02/2-32.jpgmizmghttps://marketrealist.com/2018/02/cheniere-energy-stock-after-its-4q17-earnings/2018-02-23T18:25:09.000Zdaily0.8https://media.marketrealist.com/brand-img/_st6z-mKz/0x0/uploads/2018/02/nspc-7.pngnspchttps://marketrealist.com/2018/02/oil-prices-move-higher-2/2020-11-20T22:25:29.969Zdaily0.8https://media.marketrealist.com/brand-img/6cSVkiSj6/0x0/uploads/2018/02/p1-4.jpgphttps://marketrealist.com/2018/02/interest-rate-expectations-jolted-equity-debt-alike/2020-12-04T15:52:39.816Zdaily0.8https://media.marketrealist.com/brand-img/GtAnCqGmK/0x0/uploads/2018/02/AUM-by-product-1.pngaumbyproducthttps://marketrealist.com/2018/02/what-wall-street-expects-for-lowes-4q17-revenue/2020-12-04T15:53:13.769Zdaily0.8https://media.marketrealist.com/brand-img/-rmHjKbZl/0x0/uploads/2018/02/2-27.jpgmiynwhttps://marketrealist.com/2018/02/abbott-laboratories-librelink-app-in-europe/2018-02-22T18:15:54.000Zdaily0.8https://media.marketrealist.com/brand-img/O2TJsrq_3/0x0/uploads/2018/02/freestyle-libre.pngfreestylelibrehttps://marketrealist.com/2018/02/walmarts-us-segment-is-a-key-revenue-driver/2018-02-22T14:09:03.000Zdaily0.8https://media.marketrealist.com/brand-img/mxH4250u8/0x0/uploads/2018/02/WMT-US-1.pngwmtushttps://marketrealist.com/2018/02/cannabis-stock-canopy-growth-surged-12-yesterday/2018-02-21T18:37:46.000Zdaily0.8https://media.marketrealist.com/brand-img/eQeht3k2b/0x0/uploads/2018/02/weed-2105966_1280.jpgweedhttps://marketrealist.com/2018/02/george-soros-relates-facebook-google-casinos/2020-12-04T15:52:51.341Zdaily0.8https://media.marketrealist.com/brand-img/MZt9xvvhb/0x0/uploads/2018/02/picture-5.jpgpicturehttps://marketrealist.com/2018/02/a-look-at-vanda-pharmaceuticals-product-portfolio/2018-02-23T22:17:08.000Zdaily0.8https://media.marketrealist.com/brand-img/h0Iwixump/0x0/uploads/2018/02/Hetlioz-indications-1.pnghetliozindicationshttps://marketrealist.com/2018/02/novartis-focused-expanding-multiple-sclerosis-portfolio-2018/2018-02-21T12:35:58.000Zdaily0.8https://media.marketrealist.com/brand-img/eaVUf0DDS/0x0/uploads/2018/02/Graph-18-1.pnggraphhttps://marketrealist.com/2018/02/cas-fiscal-3q18-revenue-hits-highest-growth-six-years/2018-02-20T20:50:03.000Zdaily0.8https://media.marketrealist.com/brand-img/8gvJweqf9/0x0/uploads/2018/02/CA_Revenue-Growth-1.pngcarevenuegrowthhttps://marketrealist.com/2018/02/cleveland-cliffs-us-steel-peers-soar-tariff-recommendations/2018-02-20T17:13:32.000Zdaily0.8https://media.marketrealist.com/brand-img/I7AcN0PgP/0x0/uploads/2018/02/industry-817188_1920.jpgindustryhttps://marketrealist.com/2018/02/inflation-retail-sales-indicate-economy/2018-02-20T16:29:04.000Zdaily0.8https://media.marketrealist.com/brand-img/cqOsSYhrL/0x0/uploads/2018/02/picture-4.jpgpicturehttps://marketrealist.com/2018/02/what-to-expect-from-the-euro-this-week-2/2018-02-20T13:09:55.000Zdaily0.8https://media.marketrealist.com/brand-img/1OVc8bkJ0/0x0/uploads/2018/02/5-13.jpgnsxmwhttps://marketrealist.com/2018/02/look-nxstage-medicals-financial-performance/2018-02-22T16:03:54.000Zdaily0.8https://media.marketrealist.com/brand-img/sJxZEPGfU/0x0/uploads/2018/02/NXTM-revenue-1.pngnxtmrevenuehttps://marketrealist.com/2018/02/look-regeneron-pharmaceuticals-product-pipeline/2018-02-22T18:38:03.000Zdaily0.8https://media.marketrealist.com/brand-img/tGXliYeKU/0x0/uploads/2018/02/REGN-RD-1.pngregnrdhttps://marketrealist.com/2018/02/regeneron-pharmaceuticals-kevzara-arcalyst-zaltrap/2018-02-22T18:36:14.000Zdaily0.8https://media.marketrealist.com/brand-img/lcEEo0gxT/0x0/uploads/2018/02/REGN-Arcalyst-sales-1.pngregnarcalystsaleshttps://marketrealist.com/2018/02/glaxosmithklines-valuations-after-its-4q17-earnings/2018-02-21T12:32:46.000Zdaily0.8https://media.marketrealist.com/brand-img/GWgSyr79o/0x0/uploads/2018/02/Chart-08-2-1.jpgcharthttps://marketrealist.com/2018/02/promacta-jakavi-tafinlar-mekinist-may-boost-novartis-oncology-segment-revenues-2018/2018-02-20T14:02:07.000Zdaily0.8https://media.marketrealist.com/brand-img/CjbJBOPq4/0x0/uploads/2018/02/Graph-13-1.pnggraphhttps://marketrealist.com/2018/02/kymriah-may-emerge-robust-treatment-option-dlbcl-indication/2018-02-19T15:31:52.000Zdaily0.8https://media.marketrealist.com/brand-img/8ZArTBPgX/0x0/uploads/2018/02/Graph-11-1.pnggraphhttps://marketrealist.com/2018/02/novartis-kymriah-becomes-first-gene-therapy-approved-u-s/2018-02-19T14:02:54.000Zdaily0.8https://media.marketrealist.com/brand-img/ZchZaHmUA/0x0/uploads/2018/02/Graph-10-2-1.pnggraphhttps://marketrealist.com/2018/02/cosentyx-effective-resolving-enthesitis-psoriatic-arthritis-patients/2018-02-16T20:35:08.000Zdaily0.8https://media.marketrealist.com/brand-img/AhpnRKqZz/0x0/uploads/2018/02/Graph-8-2-1.pnggraphhttps://marketrealist.com/2018/02/can-royalty-streaming-companies-sustain-outperformance-2018/2020-12-04T15:53:33.163Zdaily0.8https://media.marketrealist.com/brand-img/O8SsutduP/0x0/uploads/2018/02/Royalty.pngroyaltyhttps://marketrealist.com/2018/02/how-symantec-plans-to-bring-growth-to-its-enterprise-segment/2018-02-16T15:32:08.000Zdaily0.8https://media.marketrealist.com/brand-img/u9y4dm8bJ/0x0/uploads/2018/02/enterprise-security-statista-1.pngenterprisesecuritystatistahttps://marketrealist.com/2018/02/inside-alphabets-capital-allocation-strategy/2018-02-16T15:31:39.000Zdaily0.8https://media.marketrealist.com/brand-img/QhWDWOXyZ/0x0/uploads/2018/02/13-4.pngmtmtnahttps://marketrealist.com/2018/02/cosentyx-may-emerge-as-leading-psoriasis-drug-in-future-years/2018-02-16T19:05:03.000Zdaily0.8https://media.marketrealist.com/brand-img/-P0sMS3iD/0x0/uploads/2018/02/Graph-7-2-1.pnggraphhttps://marketrealist.com/2018/02/dominos-valuation-multiple-compared-peers-2/2018-02-16T12:33:13.000Zdaily0.8https://media.marketrealist.com/brand-img/GNTdNLwv1/0x0/uploads/2018/02/4-14.jpgncxnahttps://marketrealist.com/2018/02/whats-wall-streets-forecast-for-nabors-industries/2020-11-20T19:09:52.549Zdaily0.8https://media.marketrealist.com/brand-img/6mpl0IKaq/0x0/uploads/2018/02/Broker-Recommendations-5-1.jpgbrokerrecommendationshttps://marketrealist.com/2018/02/need-know-apples-iphone-x-production-target/2018-02-14T21:15:02.000Zdaily0.8https://media.marketrealist.com/brand-img/cElzc_M7i/0x0/uploads/2018/02/3-19.pngmyxoqhttps://marketrealist.com/2018/02/look-evercores-business-model/2018-02-15T12:35:03.000Zdaily0.8https://media.marketrealist.com/brand-img/Szi2Bkrj3/0x0/uploads/2018/02/Geographical-diversification-1.pnggeographicaldiversificationhttps://marketrealist.com/2018/02/will-hps-personal-systems-business-perform-fiscal-2017/2018-02-14T19:15:03.000Zdaily0.8https://media.marketrealist.com/brand-img/GUqnwoCT4/0x0/uploads/2018/02/4-20.pngncymahttps://marketrealist.com/2018/02/armour-beat-4q17-sales-reported-line-earnings/2018-02-14T19:31:42.000Zdaily0.8https://media.marketrealist.com/brand-img/FEd1NvC13/0x0/uploads/2018/02/jogging-2343558_1280.jpgjogginghttps://marketrealist.com/2018/02/oecds-crude-oil-inventories-near-june-2015-low/2019-09-16T01:02:13.000Zdaily0.8https://media.marketrealist.com/brand-img/BV3P4gjo-/0x0/uploads/2018/02/OECD.pngoecdhttps://marketrealist.com/2018/02/prospects-investment-income-fell/2018-02-14T16:05:03.000Zdaily0.8https://media.marketrealist.com/brand-img/vhEen-2oB/0x0/uploads/2018/02/DY-4.pngdyhttps://marketrealist.com/2018/02/gained-consumer-sector-last-week-2/2018-02-14T13:43:48.000Zdaily0.8https://media.marketrealist.com/brand-img/MCP0WC3fc/0x0/uploads/2018/02/gainers-2.jpggainershttps://marketrealist.com/2018/02/pfizers-rare-disease-segment-perform-2017/2018-02-16T14:01:13.000Zdaily0.8https://media.marketrealist.com/brand-img/mwH_F_LrK/0x0/uploads/2018/02/rare-diseases-1.pngrarediseaseshttps://marketrealist.com/2018/02/yum-brands-expanding-business/2018-02-14T14:03:09.000Zdaily0.8https://media.marketrealist.com/brand-img/jFoc0jGnO/0x0/uploads/2018/02/4-9.jpgnchttps://marketrealist.com/2018/02/detailed-discussion-urban-outfitters-growth-strategy/2018-02-13T21:15:08.000Zdaily0.8https://media.marketrealist.com/brand-img/eOq3KB52T/0x0/uploads/2018/02/URBN-2-1.pngurbnhttps://marketrealist.com/2018/02/pfizers-peri-loe-products-perform-2017/2018-02-15T14:00:45.000Zdaily0.8https://media.marketrealist.com/brand-img/7GNzPE5Rb/0x0/uploads/2018/02/LOE.pngloehttps://marketrealist.com/2018/02/pfizers-vaccines-perform-4q17-2017/2018-02-13T20:35:03.000Zdaily0.8https://media.marketrealist.com/brand-img/fIqsDKrgR/0x0/uploads/2018/02/Vaccines.pngvaccineshttps://marketrealist.com/2018/02/how-analysts-view-copper-miners-amid-the-market-carnage/2018-02-13T14:50:52.000Zdaily0.8https://media.marketrealist.com/brand-img/AzuNpMhuh/0x0/uploads/2018/02/trade-2328525_1920.jpgtradehttps://marketrealist.com/2018/02/alibaba-stock-fell-following-3q18-earnings-release/2020-12-04T15:53:33.390Zdaily0.8https://media.marketrealist.com/brand-img/TyCNffi6z/0x0/uploads/2018/02/9-10.pngosxmahttps://marketrealist.com/2018/02/will-drive-dividend-rcl/2018-02-12T16:46:52.000Zdaily0.8https://media.marketrealist.com/brand-img/_aY3OUaUk/0x0/uploads/2018/02/rev-eps-rcl-1.pngrevepsrclhttps://marketrealist.com/2018/02/key-events-steer-oil-gas-prices-week/2018-02-12T19:25:03.000Zdaily0.8https://media.marketrealist.com/brand-img/dqw-t_kqW/0x0/uploads/2018/02/p7.pngphttps://marketrealist.com/2018/02/pfizers-bosulif-perform-4q17-2017/2018-02-12T19:10:03.000Zdaily0.8https://media.marketrealist.com/brand-img/uN10RgYAB/0x0/uploads/2018/02/Bosulif.pngbosulifhttps://marketrealist.com/2018/02/uks-manufacturing-pmi-gradually-falling/2018-02-12T17:35:29.000Zdaily0.8https://media.marketrealist.com/brand-img/ZV3g0FvrW/0x0/uploads/2018/02/UK-Manufacturing-PMI-in-January-2018-2018-02-05-1.jpgukmanufacturingpmiinjanuaryhttps://marketrealist.com/2018/02/inside-visas-operating-expenses/2018-02-12T18:05:03.000Zdaily0.8https://media.marketrealist.com/brand-img/YFnWC98YG/0x0/uploads/2018/02/net-income-margin-1.pngnetincomemarginhttps://marketrealist.com/2018/02/will-ciscos-infinite-video-platform-target-ott-industry/2018-02-09T20:50:26.000Zdaily0.8https://media.marketrealist.com/brand-img/lmscVmjeI/0x0/uploads/2018/02/OTT-market-growth-in-2022-1.pngottmarketgrowthinhttps://marketrealist.com/2018/02/google-easing-mobile-payments-google-pay/2020-11-20T16:22:14.062Zdaily0.8https://media.marketrealist.com/brand-img/EYIot9TKx/0x0/uploads/2018/02/mobile-payment-transaction-users-in-US-1.pngmobilepaymenttransactionusersinushttps://marketrealist.com/2018/02/why-quit-rate-indicates-a-strong-us-employment-market/2018-02-09T19:40:03.000Zdaily0.8https://media.marketrealist.com/brand-img/Pls4HclIm/0x0/uploads/2018/02/2-11.jpgmixmqhttps://marketrealist.com/2018/02/broadcom-call-home/2020-12-04T15:52:56.412Zdaily0.8https://media.marketrealist.com/brand-img/Y68F2-v6u/0x0/uploads/2018/02/9-6.pngoshttps://marketrealist.com/2018/02/raymond-james-financial-compared-peers/2018-02-12T14:02:25.000Zdaily0.8https://media.marketrealist.com/brand-img/LlsGtXWXX/0x0/uploads/2018/02/Peers-3.pngpeershttps://marketrealist.com/2018/02/deeper-look-financial-performance-valeant-pharmaceuticals/2018-02-09T12:34:41.000Zdaily0.8https://media.marketrealist.com/brand-img/VEKlgvVbB/0x0/uploads/2018/02/VRX-revenue-1.pngvrxrevenuehttps://marketrealist.com/2018/02/look-performance-amgens-neulasta-enbrel-4q17-2017/2018-02-09T14:02:46.000Zdaily0.8https://media.marketrealist.com/brand-img/I4qRJYso8/0x0/uploads/2018/02/Enbrel-and-Neulasta-1.pngenbrelandneulastahttps://marketrealist.com/2018/02/amgens-xgeva-prolia-performed-4q17/2018-02-09T12:33:39.000Zdaily0.8https://media.marketrealist.com/brand-img/SIwsJuxKe/0x0/uploads/2018/02/Prolia-and-Xgeva-1.pngproliaandxgevahttps://marketrealist.com/2018/02/look-crown-castles-business-model/2018-02-08T14:05:03.000Zdaily0.8https://media.marketrealist.com/brand-img/svqhXwol-/0x0/uploads/2018/02/factors.pngfactorshttps://marketrealist.com/2018/02/duke-energy-southern-companys-current-valuations/2019-10-10T01:54:57.000Zdaily0.8https://media.marketrealist.com/brand-img/QbCGW9GOO/0x0/uploads/2018/02/xlu-stk-2-1.jpgxlustkhttps://marketrealist.com/2018/02/look-ablynx-sanofis-existing-partnership/2018-02-08T15:31:42.000Zdaily0.8https://media.marketrealist.com/brand-img/EXllJid7G/0x0/uploads/2018/02/ablynx-sanofi-partnership-1.pngablynxsanofipartnershiphttps://marketrealist.com/2018/02/analysts-view-etrade-financial-february-2018/2018-02-08T15:31:36.000Zdaily0.8https://media.marketrealist.com/brand-img/sUfYzPENZ/0x0/uploads/2018/02/analysts-2.pnganalystshttps://marketrealist.com/2018/02/why-fireeye-could-be-seen-as-an-acquisition-target/2020-08-21T12:47:55.859Zdaily0.8https://media.marketrealist.com/brand-img/LRZDOPAJa/0x0/uploads/2018/02/subscription-model-1.pngsubscriptionmodelhttps://marketrealist.com/2018/02/why-fireeye-acquired-x15-software/2018-02-06T21:50:02.000Zdaily0.8https://media.marketrealist.com/brand-img/wtbptkKO6/0x0/uploads/2018/02/x15.pngxhttps://marketrealist.com/2018/02/zynga-spending-cash/2020-11-20T21:28:19.285Zdaily0.8https://media.marketrealist.com/brand-img/oz3xkdecn/0x0/uploads/2018/02/6-4.pngnihttps://marketrealist.com/2018/02/ak-steel-face-challenges-meeting-goals/2020-12-04T15:53:34.806Zdaily0.8https://media.marketrealist.com/brand-img/MDWQ1elxa/0x0/uploads/2018/02/part-6-long-term-1.pngpartlongtermhttps://marketrealist.com/2018/02/apple-views-fiscal-2q18/2020-12-04T15:53:13.880Zdaily0.8https://media.marketrealist.com/brand-img/U-t2Q61Eo/0x0/uploads/2018/02/10-2.pngmtatmghttps://marketrealist.com/2018/02/utility-sector-showed-inverse-direction-sp-500-january/2018-02-06T14:04:02.000Zdaily0.8https://media.marketrealist.com/brand-img/Mgfr7i6eD/0x0/uploads/2018/02/Utility-Sector-1.jpgutilitysectorhttps://marketrealist.com/2018/02/japanese-yen-depreciated-dollar-last-week/2018-02-06T14:03:47.000Zdaily0.8https://media.marketrealist.com/brand-img/gF6GZBF-j/0x0/uploads/2018/02/7.jpgnwhttps://marketrealist.com/2018/02/seen-short-term-bottom-dollar/2020-12-04T15:53:25.826Zdaily0.8https://media.marketrealist.com/brand-img/-zs25kpxr/0x0/uploads/2018/02/3-4.jpgmyhttps://marketrealist.com/2018/02/expect-dishs-4q17-revenue/2020-12-04T15:53:28.734Zdaily0.8https://media.marketrealist.com/brand-img/UXKXQ3kdE/0x0/uploads/2018/01/DISH_total-Revenue_3Q17-1.pngdishtotalrevenueqhttps://marketrealist.com/2018/02/key-technical-levels-tesla-stock-4q17-event/2020-11-20T18:16:26.400Zdaily0.8https://media.marketrealist.com/brand-img/J73fpbeS_/0x0/uploads/2018/01/8-25.pngocynqhttps://marketrealist.com/2018/02/analysts-rating-chubb/2018-02-05T14:03:02.000Zdaily0.8https://media.marketrealist.com/brand-img/TiOk73Dto/0x0/uploads/2018/02/analysts.pnganalystshttps://marketrealist.com/2018/02/zealous-focus-sales-bodes-well-mimedx-group/2018-02-02T20:35:10.000Zdaily0.8https://media.marketrealist.com/brand-img/8X2FNZtXD/0x0/uploads/2018/01/MDXG-_revenue-growth-1.pngmdxgrevenuegrowthhttps://marketrealist.com/2018/02/biogens-biosimilars-interferons-performed-4q17/2018-02-05T12:34:40.000Zdaily0.8https://media.marketrealist.com/brand-img/TY6qrmbdQ/0x0/uploads/2018/01/Interferons.pnginterferonshttps://marketrealist.com/2018/02/biogens-spinraza-positioned-2018/2018-02-02T19:55:09.000Zdaily0.8https://media.marketrealist.com/brand-img/akd-nAzUO/0x0/uploads/2018/01/Spinraza.pngspinrazahttps://marketrealist.com/2018/02/exploring-financial-performance-cara-therapeutics/2018-02-02T14:03:31.000Zdaily0.8https://media.marketrealist.com/brand-img/_66xCPF2z/0x0/uploads/2018/01/Cara-SGA-1.pngcarasgahttps://marketrealist.com/2018/02/can-cnx-resources-report-higher-profits-4q17/2020-11-20T17:13:37.811Zdaily0.8https://media.marketrealist.com/brand-img/eEXoj8iEO/0x0/uploads/2018/01/CNX-4Q17-Pre-Net-Income2-1.pngcnxqprenetincomehttps://marketrealist.com/2018/02/why-abbott-laboratories-product-pipeline-is-expected-to-boost-2018/2018-02-05T15:32:07.000Zdaily0.8https://media.marketrealist.com/brand-img/WhWrDzpYT/0x0/uploads/2018/01/ABT-STJ-product-portfolio-2.pngabtstjproductportfoliohttps://marketrealist.com/2018/02/these-developments-impacted-abbott-laboratories-the-most-in-fiscal-2017/2019-09-14T10:44:09.000Zdaily0.8https://media.marketrealist.com/brand-img/mpz-Ed0nw/0x0/uploads/2018/01/ABT-STJ-product-portfolio.pngabtstjproductportfoliohttps://marketrealist.com/2018/02/inside-abbott-laboratories-4q17-earnings-results-key-highlights/2018-02-01T22:25:02.000Zdaily0.8https://media.marketrealist.com/brand-img/41tYDvHlI/0x0/uploads/2018/01/4Q17_highlights.pngqhighlightshttps://marketrealist.com/2018/02/hows-celgenes-abraxane-positioned-4q17/2020-11-20T15:44:44.403Zdaily0.8https://media.marketrealist.com/brand-img/psffsTb6g/0x0/uploads/2018/01/Abraxane.pngabraxanehttps://marketrealist.com/2018/02/mergers-acquisitions-open-qualcomm/2018-02-05T15:31:30.000Zdaily0.8https://media.marketrealist.com/brand-img/nOur_j9kh/0x0/uploads/2018/01/A9_Semiconductors_QCOM-AVGO-product-portfolio-1.pngasemiconductorsqcomavgoproductportfoliohttps://marketrealist.com/2018/02/look-cognizants-focus-digital-transformation/2019-09-22T13:05:25.000Zdaily0.8https://media.marketrealist.com/brand-img/riXQxUHvV/0x0/uploads/2018/01/3-48.pngmyoahttps://marketrealist.com/2018/02/euronav-gener8-maritime-partners-merger/2018-02-02T15:31:31.000Zdaily0.8https://media.marketrealist.com/brand-img/wF51zoZ3M/0x0/uploads/2018/01/Balance-sheet-2-1.jpgbalancesheethttps://marketrealist.com/2018/02/analyzing-euronavs-balance-sheet-december-31/2018-02-02T12:35:03.000Zdaily0.8https://media.marketrealist.com/brand-img/WKGb2sYQu/0x0/uploads/2018/01/Balance-sheet-1.jpgbalancesheet